This App has been developed as a resource to assist Australian patients with severe allergic asthma who have been prescribed Xolair® (omalizumab) to remind them of their ongoing appointments, and for their fortnightly or monthly injections advised by their specialists.The application requires a password which can be obtained from the patients’ healthcare professional.Disclaimer: This App is...more

This App has been developed as a resource to assist Australian patients with severe allergic asthma who have been prescribed Xolair® (omalizumab) to remind them of their ongoing appointments, and for their fortnightly or monthly injections advised by their specialists.

The application requires a password which can be obtained from the patients’ healthcare professional.

Disclaimer: This App is not a medical device. This App is intended for use as a personal reminder tool only.

This App is published by Novartis Pharmaceuticals Australia Pty Limited and is intended for an Australian audience. CORP0292 December 2015.less